Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Imaflex Inc.
  6. News
  7. Summary
    IFX   CA4524352099

IMAFLEX INC.

(IFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Imaflex Inc. Announces Positive Final Independent Results from the Advaseal Efficacy TRIA

09/10/2020 | 07:16am EST

Imaflex Inc. announced positive final independent results from the ADVASEAL® Efficacy Trial, designed to determine ADVASEAL's® efficacy as a fumigant replacement for field grown fresh market tomatoes in Florida. Two types of the new ADVASEAL® were compared, Grade A and Grade B (collectively "ADVASEAL®"), to the best grower fumigation standard. Both ADVASEAL® films used the same amount of active ingredients, however they differed in coating structure. The current grower standard calls for approximately 660 pounds of a broad- spectrum fumigant mixture (PIC-CLOR 60 and K-PAM®1) per treated acre. In comparison, ADVASEAL's® clean technology uses over 95% less pesticides, resulting in lower application costs and environmental benefits. Total and marketable yields were statistically the same between treatments. Similarly, estimated gross returns, based on the average US Department of Agriculture (USDA) market value, were not significantly different between plots using ADVASEAL® and those using the conventional grower standard. A numerical difference was observed for harvested tomatoes, whereby fumigated plots yielded more large tomatoes and ADAVSEAL® plots yielded a greater number of extra-large tomatoes. Nutsedge (weed) control was more than 30% better with ADVASEAL® versus the grower standard. Nutsedge, often called the "world's worst weed", is an aggressive, invasive weed that can drastically reduce crop yields. Crop vigor ratings on plants and roots were good, but the grower standard was slightly more robust mid-season. However, by the end of the study whole plant and root vigor differences were not significant between treatments. Control of root galls and nematode populations were not significantly different between the fumigated and ADVASEAL® treatments. Parasitic nematodes cause irregular swelling of roots, called galls. Other symptoms of root gall include stunted growth and plant wilting. Fusarium (fungi) severity ratings on plants were not significantly different between treatments. For roots, ADVASEAL® Grade B treated plots showed superior fusarium control over Grade A plots. Fusarium is a widely spread soil fungi that first infects the roots and later the plant, causing it to wilt, wither and die.


ę S&P Capital IQ 2020
All news about IMAFLEX INC.
11/24Imaflex Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Septe..
CI
11/24Imaflex Announces Top and Bottom Line Growth for Q3 2021 and Provides Business Update
AQ
08/25Imaflex Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
08/25IMAFLEX : Announces Strong Q2 2021 Results and Provides Business Update
AQ
06/17IMAFLEX : Announces Results of Annual General Meeting of Shareholders
AQ
05/26IMAFLEX : Reports Strong Q1 2021 Results and Provides Business Update
AQ
04/15IMAFLEX : Reports Strong Q4 and FY 2020 Results and Provides Business Update
AQ
01/25IMAFLEX : Announces Positive Independent Results for the ADVASEAL« Release Study
AQ
01/25Imaflex Announces Positive Independent Results for the ADVASEAL Release Study
CI
2020Imaflex Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
More news
Financials
Sales 2021 108 M 84,6 M 84,6 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 67,1 M 52,5 M 52,5 M
Capi. / Sales 2021 0,62x
Capi. / Sales 2022 0,65x
Nbr of Employees 222
Free-Float 54,2%
Chart IMAFLEX INC.
Duration : Period :
Imaflex Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 1,30 CAD
Average target price 1,75 CAD
Spread / Average Target 34,6%
Managers and Directors
Joseph Abbandonato Chairman, President & Chief Executive Officer
Giancarlo Santella Chief Financial Officer
Gerald R. Phelps Vice President-Operations
Michel Baril Independent Director
Philip Nolan Independent Director
Sector and Competitors
1st jan.Capi. (M$)
IMAFLEX INC.26.92%52
BERRY GLOBAL GROUP, INC.27.44%9 710
APTARGROUP, INC.-8.05%8 286
FP CORPORATION-13.61%2 775
SCIENTEX BERHAD6.94%1 653
EASTERN POLYMER GROUP PUBLIC COMPANY LIMITED60.56%947